(Q54010104)

23 May 2018

title

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. (English)

1 reference

23 May 2018

1 reference

Diamond T

1

1 reference

23 May 2018

McGuigan L

series ordinal

2

1 reference

23 May 2018

Barbagallo S

series ordinal

3

1 reference

23 May 2018

Bryant C

series ordinal

4

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 May 1995

1 reference

23 May 2018

American Journal of Medicine

published in

1 reference

23 May 2018

volume

98

1 reference

23 May 2018

issue

5

1 reference

23 May 2018

page(s)

459-463

1 reference

23 May 2018

Steroid-induced fractures and bone loss in patients with asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Bone histomorphometry in glucocorticoid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Pathogenesis and treatment of steroid osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Effect of glucocorticoids on bone resorption in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Serum osteocalcin concentrations in Paget's disease of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Reproducibility of lateral spine scans using dual energy X-ray absorptiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Quantitative computed tomography for prediction of vertebral fracture risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Is steroid-induced osteoporosis preventable?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Management of corticosteroid-induced osteoporosis: a clinician's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980345-3

10.1016/S0002-9343(99)80345-3

7 January 2021

Identifiers

DOI

1 reference

23 May 2018

release_j3mh2ivz5vbynmgnj4aklwmj44

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j3mh2ivz5vbynmgnj4aklwmj44

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 May 2018